3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Stomach Neoplasms
4
Peritoneal Neoplasms
4
Ovarian Neoplasms
3
Fallopian Tube Neoplasms
3
Sarcoma
1
Rhabdomyosarcoma
1
Recurrence
1
Rectal Neoplasms
1
Peritoneal Metastases From Gastric Cancer
1
Peritoneal Metastases From Colorectal Cancer
1
Pelvic Neoplasms
1
Mesothelioma, Malignant
1
Liposarcoma
1
Hyperthermia
1
Desmoplastic Small Round Cell Tumor
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Interventions
Capecitabine
35
Oxaliplatin
32
Fluorouracil
29
Leucovorin
26
Irinotecan
22
Bevacizumab
19
Cetuximab
17
Radiotherapy
16
Radiation
11
Surgical Procedures, Operative
6
Radiotherapy, Intensity-Modulated
5
Gene Expression Profiling
5
Chemotherapy, Adjuvant
5
Celecoxib
5
Neoadjuvant Therapy
4
Immunohistochemistry
4
Biopsy
4
Amplified Fragment Length Polymorphism Analysis
4
cediranib
3
Reverse Transcriptase Polymerase Chain Reaction
3
Receptor Protein-Tyrosine Kinases
3
Folfox protocol
3
Drug Therapy
3
Cisplatin
3
sargramostim
2
regorafenib
2
pembrolizumab
2
fludarabine phosphate
2
aldesleukin
2
Surveys and Questionnaires
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Rectal Neoplasms
×
Hyperthermic Intraperitoneal Chemotherapy
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled